[1]
Hauber, PhD, A.B., Fleischmann, PhD, J., Lothgren, PhD, M., Wilson, MSPH, M., Lam, MHEcon, A., Dubois, MD, D. and Sabatowski, MD, R. 2018. Economic evaluation of OROS® hydromorphone for chronic pain: A Pan-European perspective. Journal of Opioid Management. 7, 4 (Jan. 2018), 287–296. DOI:https://doi.org/10.5055/jom.2011.0070.